- MeSH
- časná detekce nádoru metody psychologie trendy MeSH
- lidé MeSH
- nádory * prevence a kontrola MeSH
- Check Tag
- lidé MeSH
BACKGROUND: Public awareness of colorectal cancer (CRC) and uptake of CRC screening remain challenges. The viewpoints of the target population (asymptomatic individuals older than 50) regarding CRC screening information sources and the reasons for and against participation in CRC screening are not well known in the Czech Republic. This study aimed to acquire independent opinions from the target population independently on the health system. AIM: To investigate the viewpoints of the target population regarding the source of information for and barriers and facilitators of CRC screening. METHODS: A survey among relatives (aged 50 and older) of university students was conducted. Participants answered a questionnaire about sources of awareness regarding CRC screening, reasons for and against participation, and suggestions for improvements in CRC screening. The effect of certain variables on participation in CRC screening was analyzed. RESULTS: Of 498 participants, 478 (96%) respondents had some information about CRC screening and 375 (75.3%) had participated in a CRC screening test. General practitioners (GPs) (n = 319, 64.1%) and traditional media (n = 166, 33.3%) were the most common information sources regarding CRC screening. A lack of interest or time and a fear of colonoscopy or positive results were reported as reasons for non-participation. Individuals aged > 60 years [adjusted odds ratio (aOR) = 2.30, 95% confidence interval (CI) (1.42-3.71), P = 0.001], females (aOR = 1.95, 95%CI (1.26-3.01) P = 0.003), and relatives of CRC patients (aOR = 4.17, 95%CI (1.82-9.58) P = 0.001) were more likely to participate in screening. Information regarding screening provided by physicians - GPs: (aOR = 8.11, 95%CI (4.90-13.41), P < 0.001) and other specialists (aOR = 4.19, 95%CI (1.87-9.38), P = 0.001) increased participation in screening. Respondents suggested that providing better explanations regarding screening procedures and equipment for stool capturing could improve CRC screening uptake. CONCLUSION: GPs and other specialists play crucial roles in the successful uptake of CRC screening. Reduction of the fear of colonoscopy and simple equipment for stool sampling might assist in improving the uptake of CRC screening.
- MeSH
- adherence pacienta psychologie statistika a číselné údaje MeSH
- časná detekce nádoru metody psychologie statistika a číselné údaje MeSH
- kolonoskopie psychologie statistika a číselné údaje MeSH
- kolorektální nádory diagnóza prevence a kontrola MeSH
- lidé středního věku MeSH
- lidé MeSH
- okultní krev MeSH
- plošný screening psychologie statistika a číselné údaje MeSH
- průřezové studie MeSH
- průzkumy a dotazníky statistika a číselné údaje MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- strach psychologie MeSH
- věkové faktory MeSH
- zdraví - znalosti, postoje, praxe MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
Karcinom prsu je v současné době nejčastějším zhoubným nádorem u žen a incidence onemocnění stále narůstá. Ročně je v České republice zjištěno téměř 6.500 nových případů onemocnění a přibližně 2.000 žen ročně tomuto onemocnění podlehne. Karcinom prsu zaujímá prvenství mezi příčinami úmrtí u žen ve věkové kategorii 20-54 let. Cílem tohoto příspěvku je poukázat na preventivní programy a tím na včasné odhalení karcinomu prsu u žen.
Breast cancer is currently the most common type of cancer between women and the incidence of this type of cancer is growing. Annually, nearly 6,500 new cases of this disease are detected in the Czech Republic, and approximately 2,000 women per year pass away because of this illness. Breast cancer is leading cause of death among young women from the age 20 to the age 54. The aim of this article is to point out preventative programs and thus the early detection of breast cancer.
